Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fanelli

Showing results (51-60 of 220) with videos related to

Pageof 22
Sort By:
Annals of Translational Medicine|February 12, 2019
Real-time continuous glucose monitoring decreases the risk of severe hypoglycemia in people with type 1 diabetes and impaired awareness of hypoglycemiaPaola Lucidi, Francesca Porcellati, Geremia B Bolli, et al.
Diabetes Care|November 23, 2013
Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetesFrancesca Porcellati, Paola Lucidi, Geremia B Bolli, et al.
Current Diabetes Reports|August 20, 2018
Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor TechnologyPaola Lucidi, Francesca Porcellati, Geremia B Bolli, et al.
Diabetes Care|November 26, 2015
How to Accurately Establish Pharmacokinetics/Pharmacodynamics of Long-Acting Insulins in Humans: Relevance to Biosimilar InsulinsFrancesca Porcellati, Paola Lucidi, Geremia B Bolli, et al.
Diabetes Care|February 20, 2021
Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136Geremia B Bolli, Francesca Porcellati, Paola Lucidi, et al.
Diabetes/Metabolism Research and Reviews|November 20, 2004
Insulin therapy and hypoglycaemia: the size of the problemCarmine G Fanelli, Francesca Porcellati, Simone Pampanelli, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 15, 2006
Glucagon: the effects of its excess and deficiency on insulin actionC G Fanelli, F Porcellati, P Rossetti, et al.
American Journal of Industrial Medicine|April 23, 1999
Risk of hepatitis C virus infection in a population exposed to biological materialsA Trevisan, F Bicciato, G Fanelli, et al.
Minerva Anestesiologica|January 5, 2002
Continuous peripheral block in foot surgeryL Bertini, B Borghi, P Grossi, et al.
Diabetes, Obesity & Metabolism|October 1, 2020
Equipotency of insulin glargine 300 and 100 U/mL with intravenous dosing but differential bioavailability with subcutaneous dosing in dogsUlrich Werner, Norbert Tennagels, Carmine G Fanelli, et al.
Pageof 22

Showing results (51-60 of 220) with videos related to

Sort By:
Pageof 22
Annals of Translational Medicine|February 12, 2019
Real-time continuous glucose monitoring decreases the risk of severe hypoglycemia in people with type 1 diabetes and impaired awareness of hypoglycemiaPaola Lucidi, Francesca Porcellati, Geremia B Bolli, et al.
Diabetes Care|November 23, 2013
Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetesFrancesca Porcellati, Paola Lucidi, Geremia B Bolli, et al.
Current Diabetes Reports|August 20, 2018
Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor TechnologyPaola Lucidi, Francesca Porcellati, Geremia B Bolli, et al.
Diabetes Care|November 26, 2015
How to Accurately Establish Pharmacokinetics/Pharmacodynamics of Long-Acting Insulins in Humans: Relevance to Biosimilar InsulinsFrancesca Porcellati, Paola Lucidi, Geremia B Bolli, et al.
Diabetes Care|February 20, 2021
Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136Geremia B Bolli, Francesca Porcellati, Paola Lucidi, et al.
Diabetes/Metabolism Research and Reviews|November 20, 2004
Insulin therapy and hypoglycaemia: the size of the problemCarmine G Fanelli, Francesca Porcellati, Simone Pampanelli, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 15, 2006
Glucagon: the effects of its excess and deficiency on insulin actionC G Fanelli, F Porcellati, P Rossetti, et al.
American Journal of Industrial Medicine|April 23, 1999
Risk of hepatitis C virus infection in a population exposed to biological materialsA Trevisan, F Bicciato, G Fanelli, et al.
Minerva Anestesiologica|January 5, 2002
Continuous peripheral block in foot surgeryL Bertini, B Borghi, P Grossi, et al.
Diabetes, Obesity & Metabolism|October 1, 2020
Equipotency of insulin glargine 300 and 100 U/mL with intravenous dosing but differential bioavailability with subcutaneous dosing in dogsUlrich Werner, Norbert Tennagels, Carmine G Fanelli, et al.
Pageof 22